This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: The goal of this project is to test the ability of CpG ODN adjuvant a therapeutic vaccine and elicit protective anti-SIV immune responses in infected monkeys.
Showing the most recent 10 out of 408 publications